Hong Kong Scientist: Existing jabs will not be as effective against Omicron covid variant
|One of Hong Kong's leading microbiologists and professors at the University of Hong Kong (HKU) warns that the Omicron covid variant poses risks to the global community, as the vaccines are unlikely to be as effective against the new strain.
Key quotes
"This particular strain has all the characteristics of previous mutations - and more.”
“So I believe (existing vaccines) will not be as effective, but how much it will reduce efficacy is still hard to predict.”
“Whether vaccines could be entirely ineffective, or reduce efficacy by 20 percent or 40 percent, is still too hard to say."
Moderna Inc.’s CEO Stéphane Bancel predicted the same on the vaccine’s efficacy against this new strain, which sent the risk sentiment into a tailspin.
These above comments, however, seem to have a little impact the prevalent upbeat market mood, with the S&P 500 futures up 0.86% on the day.
The safe-haven US dollar is down 0.10% so far, despite the uptick in the Treasury yields across the curve.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.